Tetz C Lee1, Zhezhen Jin2, Shunichi Homma1, Koki Nakanishi1, Mitchell S V Elkind3, Tatjana Rundek4, Aylin Tugcu1, Kenji Matsumoto1, Ralph L Sacco5, Marco R Di Tullio6. 1. Department of Medicine, Columbia University, New York, New York. 2. Department of Biostatistics, Columbia University, New York, New York. 3. Departments of Neurology and Epidemiology, Columbia University, New York, New York. 4. Department of Neurology, Miller School of Medicine, University of Miami, Miami, Florida; Department of Public Health Sciences, Miller School of Medicine, University of Miami, Miami, Florida. 5. Department of Neurology, Miller School of Medicine, University of Miami, Miami, Florida; Department of Human Genetics, Miller School of Medicine, University of Miami, Miami, Florida. 6. Department of Medicine, Columbia University, New York, New York. Electronic address: md42@columbia.edu.
Abstract
BACKGROUND: Left ventricular (LV) hypertrophy is an independent risk factor for cardiovascular outcomes. There are limited data about modifiable factors associated with progression of LV hypertrophy in older adults. Our objective is to describe the changes in LV mass and geometry over time in a predominantly older multiethnic cohort and to identify possible predictors of changes over time. METHODS: We analyzed data from participants in the Northern Manhattan Study who underwent serial echocardiographic studies, comparing the baseline and the most recent echocardiograms. We recorded changes in LV mass and geometry and correlated them with baseline characteristics using linear regression models. RESULTS: There were 826 participants (mean age, 64.2 ± 8.0 years) included in the analysis (time between measurements, 8.5 ± 2.7 years). Overall, LV mass index increased from 45.0 ± 12.7 to 50.3 ± 14.6 g/m2.7 (P < .001). There were 548 participants (66.3%) with LV mass increase; 258 individuals (31.2%) showed worsening LV geometry. Multivariable analysis showed that change in LV mass index was independently associated with baseline LV mass index (β estimate, -17.000 [standard error, 1.508]; P < .001), hypertension (2.094 [0.816], P = .011), body mass index (0.503 [0.088], P < .001), and waist-to-hip ratio (1.031 [0.385], P = .008). Both waist-to-hip ratio and waist-to-height ratio remained significantly associated with LV mass increase even after adjusting for body mass index (P = .008 and P = .036, respectively). CONCLUSIONS: Regardless of race/ethnicity, LV mass progressed over time in older adults. We also observed that worsening geometry was frequent. Assessment of central obesity in the older population is important because indicators of central obesity add prognostic value over body mass index for the risk of LV mass increase.
BACKGROUND:Left ventricular (LV) hypertrophy is an independent risk factor for cardiovascular outcomes. There are limited data about modifiable factors associated with progression of LV hypertrophy in older adults. Our objective is to describe the changes in LV mass and geometry over time in a predominantly older multiethnic cohort and to identify possible predictors of changes over time. METHODS: We analyzed data from participants in the Northern Manhattan Study who underwent serial echocardiographic studies, comparing the baseline and the most recent echocardiograms. We recorded changes in LV mass and geometry and correlated them with baseline characteristics using linear regression models. RESULTS: There were 826 participants (mean age, 64.2 ± 8.0 years) included in the analysis (time between measurements, 8.5 ± 2.7 years). Overall, LV mass index increased from 45.0 ± 12.7 to 50.3 ± 14.6 g/m2.7 (P < .001). There were 548 participants (66.3%) with LV mass increase; 258 individuals (31.2%) showed worsening LV geometry. Multivariable analysis showed that change in LV mass index was independently associated with baseline LV mass index (β estimate, -17.000 [standard error, 1.508]; P < .001), hypertension (2.094 [0.816], P = .011), body mass index (0.503 [0.088], P < .001), and waist-to-hip ratio (1.031 [0.385], P = .008). Both waist-to-hip ratio and waist-to-height ratio remained significantly associated with LV mass increase even after adjusting for body mass index (P = .008 and P = .036, respectively). CONCLUSIONS: Regardless of race/ethnicity, LV mass progressed over time in older adults. We also observed that worsening geometry was frequent. Assessment of central obesity in the older population is important because indicators of central obesity add prognostic value over body mass index for the risk of LV mass increase.
Authors: Wolfgang Lieb; Philimon Gona; Martin G Larson; Jayashri Aragam; Michael R Zile; Susan Cheng; Emelia J Benjamin; Ramachandran S Vasan Journal: JACC Cardiovasc Imaging Date: 2014-08-13
Authors: Waqas T Qureshi; J Adam Leigh; Katrina Swett; Ajay Dharod; Matthew A Allison; Jianwen Cai; Franklyn Gonzalez; Barry E Hurwitz; Sanjiv J Shah; Ankit A Desai; Daniel M Spevack; Carlos J Rodriguez Journal: Circ Cardiovasc Imaging Date: 2016-01 Impact factor: 7.792
Authors: Ian J Neeland; Sachin Gupta; Colby R Ayers; Aslan T Turer; J Eduardo Rame; Sandeep R Das; Jarett D Berry; Amit Khera; Darren K McGuire; Gloria L Vega; Scott M Grundy; James A de Lemos; Mark H Drazner Journal: Circ Cardiovasc Imaging Date: 2013-08-08 Impact factor: 7.792
Authors: Caroline Dekkers; Frank A Treiber; Gaston Kapuku; Edwin J C G Van Den Oord; Harold Snieder Journal: Hypertension Date: 2002-05 Impact factor: 10.190
Authors: Harald Staiger; Otto Tschritter; Jürgen Machann; Claus Thamer; Andreas Fritsche; Elke Maerker; Fritz Schick; Hans-Ulrich Häring; Michael Stumvoll Journal: Obes Res Date: 2003-03
Authors: Michelle G Swainson; Alan M Batterham; Costas Tsakirides; Zoe H Rutherford; Karen Hind Journal: PLoS One Date: 2017-05-11 Impact factor: 3.240
Authors: Stamatina Iliodromiti; Carlos A Celis-Morales; Donald M Lyall; Jana Anderson; Stuart R Gray; Daniel F Mackay; Scott M Nelson; Paul Welsh; Jill P Pell; Jason M R Gill; Naveed Sattar Journal: Eur Heart J Date: 2018-05-01 Impact factor: 29.983
Authors: Sarah R Anthony; Adrienne R Guarnieri; Anamarie Gozdiff; Robert N Helsley; Albert Phillip Owens; Michael Tranter Journal: Clin Sci (Lond) Date: 2019-11-29 Impact factor: 6.124
Authors: Carlo Mannina; Zhezhen Jin; Kenji Matsumoto; Kazato Ito; Angelo Biviano; Mitchell S V Elkind; Tatjana Rundek; Shunichi Homma; Ralph L Sacco; Marco R Di Tullio Journal: Int J Cardiol Date: 2021-05-06 Impact factor: 4.039